Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
08/2008
08/07/2008WO2008093614A1 Novel hepatitis c virus inhibitor
08/07/2008WO2008092944A1 Organic molybdenum compounds and oil compositions containing the same
08/07/2008US20080188655 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188522 4-Methylpropiophenone reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008US20080188486 e.g. (1-cyclopentylmethyl-1H-indol-5-yl)-(4-isopropyl-piperazin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor; antidepressant, anxiolytic agent; obesity, cardiovascular disorders
08/07/2008US20080188475 Perhydro- or hydrophenanthrene derivatives; antiinflammatory, analgesic, anticarcinogenic, and antitumor agents; autoimmune, skin, cardiovascular, and viral diseases
08/07/2008US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine
08/07/2008US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
08/07/2008US20080187978 Anti-inflammatory medicaments
08/07/2008DE102007004698A1 Verbindungen enthaltend Organofluorochlorophosphatanionen Compounds containing Organofluorochlorophosphatanionen
08/06/2008EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951700A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/06/2008EP1951699A2 Processes for the preparation of cyclopropyl-amide derivatives
08/06/2008EP1951698A1 Iap bir domain binding compounds
08/06/2008EP1951663A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
08/06/2008EP1568702A4 Palladium complexes with heterocyclic ligands
08/06/2008EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN101235020A Substituted cinnamamide derivatives and application of the same as nerve protecting agent
08/06/2008CN101235019A 3,5-diiodo salicylaldehyde-4-(omega-aminoalkyl)morpholine metal complexes, preparation method and use thereof
08/06/2008CN100408539C Vitamin d receptor modulators
08/05/2008US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/05/2008US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407956 Benzamide inhibitors of the P2X7 receptor
08/05/2008US7407648 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
08/05/2008US7407516 variety of molecules used as oxidation bases and couplers allows a wide range of colors to be obtained; hair dye
08/05/2008CA2337098C Anthranilic acid derivatives
08/05/2008CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
07/2008
07/31/2008WO2008090429A1 Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
07/31/2008WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor
07/31/2008US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine
07/31/2008US20080182875 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide
07/31/2008US20080182837 New chemical compounds
07/31/2008US20080182798 Novel effectors of dipeptidyl peptidase IV
07/31/2008DE102007010815B3 New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents
07/30/2008EP1948630A2 Novel compounds
07/30/2008EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
07/30/2008EP1948627A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
07/30/2008EP1948626A1 Process for the preparation of delmopinol and derivatives thereof
07/30/2008EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor
07/30/2008EP1254124B1 Dipeptide nitrile cathepsin k inhibitors
07/30/2008CN101233121A PARP modulators and treatment of cancer
07/30/2008CN101230051A Method for preparing S-(alpha, alpha-dimethyl benzyl) piperidine-1-thiocarboxylic
07/30/2008CN101230023A Method for preparing azo onium diol sodium salt
07/30/2008CN101230015A Substituted cinnamic acid derivatives containing amine substituent group and expression purification cytotoxicity thereof
07/30/2008CN100407493C 非水电解质和非水电解质二次电池 The non-aqueous electrolyte and a nonaqueous electrolyte secondary battery
07/30/2008CN100406449C CDC25 phosphatase inhibitors
07/30/2008CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride
07/30/2008CN100406431C Ionic liquid electrolyte salt for storage device electrolytic solution for storage device electric double layer capacitor and secondary battery
07/30/2008CN100406007C Asthma and allergic inflammation modulators
07/29/2008US7405327 Method for the continuous production of an amine
07/29/2008US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
07/29/2008CA2361464C Compounds comprising acrylate and cyclic sec.-amine functionalities
07/29/2008CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
07/29/2008CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/29/2008CA2214323C Compounds and compositions for delivering active agents
07/29/2008CA2175767C Adhesion receptor antagonists
07/29/2008CA2168192C 4-aminobenzoylguanidine derivatives
07/24/2008WO2008087654A2 PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
07/24/2008WO2007035425A3 Cyclopropyl amines as modulators of the histamine h3 receptor
07/24/2008US20080177071 Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
07/24/2008US20080176856 Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
07/24/2008US20080176854 Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability
07/24/2008US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus
07/24/2008US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders
07/24/2008US20080176833 Dihydropyridine derivatives as useful as protein kinase inhibitors
07/24/2008US20080176763 Collection of Traceable Compounds and Uses Thereof
07/24/2008US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis
07/23/2008EP1947093A1 Substituted morpholine and thiomorpholine derivatives
07/23/2008EP1945621A1 Process to prepare amino acid derivatives
07/23/2008EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
07/23/2008EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof
07/23/2008EP1846384B1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
07/23/2008EP1735267B1 Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor
07/23/2008EP1070070B1 Method for producing grignard compounds
07/23/2008CN101228145A Organic compounds for the treatment of inflammatory or allergic conditions
07/23/2008CN101225075A Cinepazide maleate crystal system and method for making same
07/22/2008US7402704 Arylsulfones and uses related thereto
07/22/2008US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/22/2008CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors
07/17/2008US20080171870 Reacting 4-Morpholin-4-ylmethyl-benzoic acid with 1-cyclopropyl-piperazine dihydrochloride producing (4-Cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone; sleep disorders, attention deficit hyperactivity disorders (ADHD), learning and memory disorders
07/17/2008US20080171869 Condensation of 10H-dibenzo-[b,f][1,4]-thiazepin-11-one with a piperazine derivative in the presence of a titanium alkoxide catalyst; Titanium catalyst easier to handle, have low toxicity, not chlorinated, much less harmful for the environment
07/17/2008US20080171749 e.g. 2-(4-Cyclohexyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-acetonitril; antiinflammatory, antiallerge agent,autoimmune diseases; asthma, rheumatoid arthritis, atherosclerosis or allergic diseases wherein the activity of a CCR3 receptor is involved
07/17/2008US20080171742 e.g. 6-methyl-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(pyrid-2-ylamino)pyrimidine; insulin-like growth factor 1 receptor (somatomedin) antagonist; antiproliferative, antitumor, anticarcinogenic agent;
07/17/2008US20080171692 Substituted amides
07/16/2008EP1943236A2 Process for the synthesis of amine ethers
07/16/2008EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
07/16/2008EP1943213A2 Ppar modulating biaromatic compounds
07/16/2008CN101220009A Method for producing N-amido piperidine hydrochlorate
07/16/2008CN101220008A Synthesis of compound ABT-263
07/16/2008CN101220007A Method for producing repaglinide
07/16/2008CN101220006A Buflomedil production method
07/16/2008CN100402496C Compounds useful as matrix metalloprotease inhibitors
07/16/2008CN100402495C Aminoalkylamide substituted cyclohexyl derivatives
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 341